Latest News
CRO Emmes Acquires Ophthalmic Clinical Trial Service Specialist Clinical Edge
Thursday 29 September 2022

US-based clinical research organization Emmes has acquired visual acuity examiner and certification services provider Clinical Edge, the company said.

Clinical Edge trains and certifies visual function examiners at investigator sites conducting Phase I to IV ophthalmic clinical trials.

The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services.

Emmes officially rolled out the new name OptymEdge and branding ahead of the American Academy of Ophthalmology annual meeting, which takes place in Chicago from September 30 to October 3.

Headquartered in Milwaukee, Wisconsin, and founded in 2004, Clinical Edge provides visual acuity examiner and certification services.

The company's staff members ensure a high level of quality and consistency for all clinical sites participating in the conduct of ophthalmology drug, biologic and device clinical trials.

Founded in 1977, Emmes is a global, full-service Clinical Research Organization dedicated to excellence in supporting the advancement of public health and biopharmaceutical innovation.

The company's clients include numerous agencies and institutes of the US federal government and a wide range of biotechnology, pharmaceutical and medical device companies throughout the world.
Date Published: 29/09/2022